News

ProKidney: What's Happening With PROK Stock?
The company also encounters competitive risks from other organizations developing therapies for chronic kidney disease.
U.S. stock futures inch higher as tariff updates remain in focus
Stock index futures were slightly higher on Wednesday, implying another day of small moves for the market as investors ...
CoreWeave’s stock has quadrupled since the IPO — and that’s just one reason some analysts are cautious
CoreWeave is highly reliant on Microsoft for revenue. Plus, soon insiders will be able to sell shares after the post-IPO ...
After 70% Rally, Is Nebius Stock Still The Top AI Cloud Pick?
Unlike conventional hyperscalers like Amazon’s AWS or Microsoft's Azure that provide a wide range of general-purpose cloud ...
Palantir Was the Top-Performing Stock in the S&P 500 and Nasdaq-100 During the First Half of 2025. Here Is What History Says Will Happen Next.
One stock that managed to outmaneuver the various headwinds torturing the markets throughout the year, however, is data ...
Stock Market Today: Dow falls 150 points, S&P 500 and Nasdaq struggle for direction in afternoon trade
Stocks were flashing this warning signal before tariff jitters drove Dow down more than 400 points. Tesla and Apple don’t belong in the ‘Magnificent Seven’ anymore. These two hot tech stocks should ...
How Trump's One Big Beautiful Bill could be fresh fuel for the stock market's favorite AI names
Tax incentives contained in the sweeping tax and budget bill Trump signed on July 4 could provide a fresh boost to AI ...
Why Enterprise Products Partners Is A Stronger Dividend Stock Than ExxonMobil
Trade disputes and OPEC+ hikes impact ExxonMobil Corporation and Enterprise Products Partners L.P. Click for why I pick EPD ...
Microsoft Stock Is a Buy Because AI Agents Can Spur Growth, Says Analyst
Brian Schwartz of Oppenheimer & Co. upgraded Microsoft stock to Outperform from Perform, and set a price target of $600 in a ...